SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $17,205,000 | +50.8% | 683,835 | +24.9% | 0.15% | +28.0% |
| Q3 2020 | $11,406,000 | +5.2% | 547,298 | +19.9% | 0.12% | +0.9% |
| Q2 2020 | $10,844,000 | +1054.8% | 456,581 | +774.4% | 0.12% | +875.0% |
| Q1 2020 | $939,000 | +61.3% | 52,219 | +310.8% | 0.01% | +20.0% |
| Q1 2018 | $582,000 | +207.9% | 12,710 | -18.5% | 0.01% | +233.3% |
| Q1 2015 | $189,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |